MTIF2P1

Across TCGA pan-cancer cohorts, MTIF2P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MTIF2P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MTIF2P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTIF2P1 expression acts as an unfavorable survival marker, although some lineages such as OV and LUSC show a favorable association.

OV, LUSC, and READ are the cancer types where MTIF2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	III,IV	0.409	0.336	.013	28	view →
LUSC	OS	Tertile	II,III,IV	0.831	0.619	.009	25	view →
READ	OS	Median	II,III,IV	0.969	0.853	.003	19	view →
STAD	DFS	Quartile	II,III,IV	0.475	0.738	.017	19	view →
LIHC	OS	Tertile	III,IV	0.503	0.874	.003	19	view →
UCS	DFS	Tertile	III,IV	0.138	0.531	.008	18	view →
ESCA	OS	Median	III,IV	0.531	0.308	.010	18	view →
MESO	DFS	Tertile	All	0.264	0.407	.020	15	view →
ACC	DFS	Median	IV	0.063	0.426	.004	11	view →
UVM	DFS	Tertile	III,IV	0.373	0.810	.042	10	view →
LUAD	OS	Median	All	0.796	0.864	.015	8	view →
KIRP	OS	Quartile	All	0.852	1.000	.028	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MTIF2P1–OV (DFS)

Open the OV breakdown →